Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe.

Published on Jun 1, 2021in Journal of Clinical Pathology2.46
· DOI :10.1136/JCLINPATH-2020-206957
Umberto Malapelle29
Estimated H-index: 29
(University of Naples Federico II),
Pasquale Pisapia17
Estimated H-index: 17
(University of Naples Federico II)
+ 26 AuthorsGiancarlo Troncone55
Estimated H-index: 55
(University of Naples Federico II)
Sources
Abstract
AIMS: Lung cancer predictive biomarker testing is essential to select advanced-stage patients for targeted treatments and should be carried out without delays even during health emergencies, such as the coronavirus (COVID-19) outbreak. METHODS: Fifteen molecular laboratories from seven different European countries compared 4 weeks of national lockdown to a corresponding period in 2019, in terms of tissue and/or plasma-based molecular test workload, analytical platforms adopted, number of cases undergoing programmed death-ligand1 (PD-L1) expression assessment and DNA-based molecular tests turnaround time. RESULTS: In most laboratories (80.0%), tissue-based molecular test workload was reduced. In 40.0% of laboratories (6/15), the decrease was >25%, and in one, reduction was as high as 80.0%. In this instance, a concomitant increase in liquid biopsy was reported (60.0%). Remarkably, in 33.3% of the laboratories, real-time PCR (RT-PCR)-based methodologies increased, whereas highly multiplexing assays approaches decreased. Most laboratories (88.9%) did not report significant variations in PD-L1 volume testing. CONCLUSIONS: The workload of molecular testing for patients with advanced-stage lung cancer during the lockdown showed little variations. Local strategies to overcome health emergency-related issues included the preference for RT-PCR tissue-based testing methodologies and, occasionally, for liquid biopsy.
📖 Papers frequently viewed together
42 Citations
58 Citations
References24
Newest
#1Giancarlo Troncone (University of Naples Federico II)H-Index: 55
9 CitationsSource
#1Giancarlo TronconeH-Index: 55
#2Paul Hofman (French Institute of Health and Medical Research)H-Index: 81
The current COVID-19 pandemic has imposed sweeping changes in every aspect of life, not least in the way pathologists carry out their practice. Severe acute respiratory syndrome coronavirus 2 spreads quickly from person to person through respiratory droplets released in the air by infected patients. Thus, respecting strict biosafety procedures while handling potentially infected fresh tissues, liquid samples or even air-dried fixed cytological preparations, has become paramount for pathologists....
8 CitationsSource
#1Umberto Malapelle (University of Naples Federico II)H-Index: 29
#2Caterina De Luca (University of Naples Federico II)H-Index: 14
Last. Giancarlo Troncone (University of Naples Federico II)H-Index: 55
view all 12 authors...
Aims In the time of COVID-19, predictive molecular pathology laboratories must still timely select oncological patients for targeted treatments. However, the need to respect social distancing measures may delay results generated by laboratory-developed tests based on sequential steps a long hands-on time. Laboratory workflows should now be simplified. Methods The organisation of the University of Naples Federico II predictive pathology laboratory was assessed before (March–April 2019) and during...
10 CitationsSource
#1Elena Vigliar (University of Naples Federico II)H-Index: 21
#2Antonino Iaccarino (University of Naples Federico II)H-Index: 15
Last. Giancarlo Troncone (University of Naples Federico II)H-Index: 55
view all 6 authors...
Introduction The coronavirus disease 2019 (covid-19) is changing the way we practice pathology, including fine needle aspiration (FNA) diagnostics. Although recommendations have been issued to prioritise patients at high oncological risk, postponing those with unsuspicious presentations, real world data have not been reported yet. Methods The percentages of the cytological sample types processed at the University of Naples Federico II, during the first 3 weeks of Italian national lockdown were c...
32 CitationsSource
#1Claudio Bellevicine (University of Naples Federico II)H-Index: 23
#2Elena Vigliar (University of Naples Federico II)H-Index: 21
Last. Giancarlo Troncone (University of Naples Federico II)H-Index: 55
view all 3 authors...
6 CitationsSource
#1Mark J. ArendsH-Index: 65
#2Manuel Salto-Tellez ('QUB': Queen's University Belfast)H-Index: 68
Abstract The COVID-19 pandemic situation may be viewed as an opportunity to accelerate some of the ongoing transformations in modern Pathology This refers primarily to the digitalization of the practice of tissue and cellular pathology diagnostics However, it is also an opportunity to analyse the modus operandi of a discipline that has practiced in a similar manner for over 100 years The challenge is to define the next generation of interconnectivity tools that would be necessary to achieve a ne...
5 CitationsSource
#1Fabio PagniH-Index: 19
#2Umberto Malapelle (University of Naples Federico II)H-Index: 29
Last. Giancarlo Troncone (University of Naples Federico II)H-Index: 55
view all 15 authors...
A meeting among expert pathologists was held in 2019 in Rome to verify the results of the previous harmonization efforts on the PD-L1 immunohistochemical testing by scoring a representative series of non-small cell lung cancer (NSCLC) digital slides. The current paper shows the results of this digital experimental meeting and the expertise achieved by the community of Italian pathologists. PD-L1 protein expression was determined using tumor proportion score (TPS), i.e., the percentage of viable ...
7 CitationsSource
#1Daniel P Steinfort (University of Melbourne)H-Index: 27
#2Felix J.F. Herth (Heidelberg University)H-Index: 84
Last. Phan Nguyen (University of Adelaide)H-Index: 11
view all 4 authors...
ABSTRACT The SARS-CoV-2 pandemic is unprecedented in our professional lives and much effort and resources will be devoted to care of patients (and HCW) affected by this illness. We must also continue to aim for the same standard of care for our non-COVID respiratory patients, while minimizing risks of infection transmission to our colleagues. This commentary addresses the key paired issues of minimizing performance of diagnostic/staging bronchoscopy in patients with suspected/known lung cancer w...
15 CitationsSource
#1Oscar Cano-Valderrama (Complutense University of Madrid)H-Index: 4
#2Xavier MoralesH-Index: 2
Last. Antonio J. Torres (Complutense University of Madrid)H-Index: 12
view all 11 authors...
35 CitationsSource
#1Antonio Passaro (IEO: European Institute of Oncology)H-Index: 18
#2Alfredo AddeoH-Index: 21
Last. Solange PetersH-Index: 65
view all 11 authors...
The COVID-19 pandemic, characterised by a fast and global spread during the first months of 2020, has prompted the development of a structured set of recommendations for cancer care management, to maintain the highest possible standards. Within this framework, it is crucial to ensure no disruption to essential oncological services and guarantee the optimal care.This is a structured proposal for the management of lung cancer, comprising three levels of priorities, namely: tier 1 (high priority), ...
53 CitationsSource
Cited By16
Newest
The recent emergence of novel neoadjuvant and/or adjuvant therapies for early stage (I-IIIA) non-small cell lung carcinoma (NSCLC), mainly tyrosine kinase inhibitors (TKIs) targeting EGFR mutations and immunotherapy or chemo-immunotherapy, has suddenly required the evaluation of biomarkers predictive of the efficacy of different treatments in these patients. Currently, the choice of one or another of these treatments mainly depends on the results of immunohistochemistry for PD-L1 and of the stat...
Source
Lung and colorectal cancers (CRC) have two of the highest mortality rates among all cancer types, and their occurrence and the need for personalized diagnostics and subsequent therapy were not influenced by the COVID-19 pandemics. However, due to the disruption of established delivery chains, standard assays for in vitro diagnostics of those cancers were temporarily not available, forcing us to implement alternative testing methods that enabled at least basic therapy decision making. For this re...
Source
#1Ermengol ComaH-Index: 7
#2Carolina GuiriguetH-Index: 4
Last. Manuel MedinaH-Index: 4
view all 10 authors...
Objective Cancer care has been disrupted by the response of health systems to the COVID-19 pandemic, especially during lockdowns. The objective of our study is to evaluate the impact of the pandemic on the incidence of cancer diagnoses in primary care. Design Time-series study of malignant neoplasms and diagnostic procedures, using data from the primary care electronic health records from January 2014 to September 2020. Setting Primary care, Catalonia, Spain. Participants People older than 14 ye...
2 CitationsSource
#1Antonino Iaccarino (University of Naples Federico II)H-Index: 15
#2Pasquale Pisapia (University of Naples Federico II)H-Index: 17
Last. Giancarlo Troncone (University of Naples Federico II)H-Index: 55
view all 5 authors...
Since its first identification in China at the end of 2019, severe acute respiratory syndrome coronavirus 2 has rapidly spread all over the world, becoming an international healthcare emergency. In the era of coronavirus disease-2019 (COVID-19), several aspects of normal life, including those related to the medical activities, have been radically changed. Extraordinary measures have been adopted by different nations to cope with the rapid diffusion of COVID-19 all over the world. In hospitals, c...
4 CitationsSource
1 CitationsSource
#1Caterina De Luca (University of Naples Federico II)H-Index: 14
#2Gianluca Gragnano (University of Naples Federico II)H-Index: 6
Last. Giuseppe Portella (University of Naples Federico II)H-Index: 33
view all 11 authors...
AIMS To date, reverse transcriptase PCR (RT-PCR) on nasopharyngeal swabs is the 'gold standard' approach for the diagnosis of COVID-19. The need to develop easy to use, rapid, robust and with minimal hands-on time approaches are warranted. In this setting, the Idylla SARS-CoV-2 Test may be a valuable option. The aim of our study is to evaluate the analytical and clinical performance of this assay on previously tested SARS-CoV-2 people by conventional RT-PCR based approach in different settings, ...
Source
#1Antonino IaccarinoH-Index: 15
Last. Elena VigliarH-Index: 21
view all 8 authors...
Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak was declared a pandemic, the magnitude of coronavirus disease 2019 (COVID-19) has continued to grow, putting an unprecedented strain on all medical fields. Its effects on cytopathology workloads have been dramatic. Indeed, despite the implementation of several laboratory biosafety recommendations, cytological screening activities and cytological sampling of patients at low risk of malignancy have been postponed to li...
1 CitationsSource
#1Paweł Krawczyk (Medical University of Lublin)H-Index: 17
#2Dariusz M. KowalskiH-Index: 21
Last. Rafal Dziadziuszko (Gdańsk Medical University)H-Index: 41
view all 4 authors...
In all countries in the world as well as Poland, there are no recommendations regarding the testing of predictive factors qualifying non-small cell lung cancer (NSCLC) patients for molecularly targ...
Source
#1Elena Vigliar (University of Naples Federico II)H-Index: 21
#2Rima Cepurnaite (University of Naples Federico II)H-Index: 1
Last. Giancarlo Troncone (University of Naples Federico II)H-Index: 55
view all 8 authors...
Background During the current coronavirus disease 2019 (COVID-19) pandemic, the cytopathology workload has decreased remarkably worldwide as all screening and elective procedures have been postponed to prioritize the clinical management of patients at high oncological risk. In the current study, the authors provide data on the lasting impact of COVID-19 on cytopathology practice during the initial phases of the Italian postlockdown period. Methods The percentages of the cytological sample types ...
1 CitationsSource
#1Paul HofmanH-Index: 81
#2M. IliéH-Index: 1
Last. F. Bibeau (UNICAEN: University of Caen Lower Normandy)H-Index: 1
view all 80 authors...
Background This study evaluated the consequences in Europe of the COVID-19 outbreak on pathology laboratories orientated toward the diagnosis of thoracic diseases. Materials and methods A survey was sent to 71 pathology laboratories from 21 European countries. The questionnaire requested information concerning the organization of biosafety, the clinical and molecular pathology, the biobanking, the workload, the associated research into COVID-19, and the organization of education and training dur...
3 CitationsSource